These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 326665)

  • 1. Capsule size of Cryptococcus neoformans: control and relationship to virulence.
    Dykstra MA; Friedman L; Murphy JW
    Infect Immun; 1977 Apr; 16(1):129-35. PubMed ID: 326665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.
    Kwon-Chung KJ; Rhodes JC
    Infect Immun; 1986 Jan; 51(1):218-23. PubMed ID: 3079732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
    Upreti HB; Rawat DS; Das SK
    Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
    Granger DL; Perfect JR; Durack DT
    J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.
    Fromtling RA; Shadomy HJ; Jacobson ES
    Mycopathologia; 1982 Jul; 79(1):23-9. PubMed ID: 6750405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Buoyancy of
    Vij R; Cordero RJB; Casadevall A
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30404928
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
    Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
    Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic and virulence factors analyses of Cryptococcus neoformans hypoxia response.
    Kong Q; Yang R; Wang Z; Zhou W; Du X; Huang S; Jiang Y; Liu W; Sang H
    APMIS; 2017 Mar; 125(3):236-248. PubMed ID: 28233445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico.
    Fromtling RA; Abruzzo GK; Ruiz A
    Mycopathologia; 1989 Jun; 106(3):163-6. PubMed ID: 2682249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic activity of a clinical isolate of Cryptococcus neoformans.
    Brueske CH
    J Clin Microbiol; 1986 Mar; 23(3):631-3. PubMed ID: 3514663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors.
    Clancy CJ; Nguyen MH; Alandoerffer R; Cheng S; Iczkowski K; Richardson M; Graybill JR
    Microbiology (Reading); 2006 Aug; 152(Pt 8):2247-2255. PubMed ID: 16849791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans.
    Jacobson ES; Tingler MJ; Quynn PL
    Mycoses; 1989 Jan; 32(1):14-23. PubMed ID: 2664504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
    Chen SC; Muller M; Zhou JZ; Wright LC; Sorrell TC
    J Infect Dis; 1997 Feb; 175(2):414-20. PubMed ID: 9203663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging: an emergent phenotypic trait that contributes to the virulence of Cryptococcus neoformans.
    Bouklas T; Fries BC
    Future Microbiol; 2015; 10(2):191-7. PubMed ID: 25689531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
    Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga.
    Neilson JB; Ivey MH; Bulmer GS
    Infect Immun; 1978 Apr; 20(1):262-6. PubMed ID: 352931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans: size range of infectious particles from aerosolized soil.
    Neilson JB; Fromtling RA; Bulmer GS
    Infect Immun; 1977 Sep; 17(3):634-8. PubMed ID: 332630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.
    Rhodes JC; Polacheck I; Kwon-Chung KJ
    Infect Immun; 1982 Jun; 36(3):1175-84. PubMed ID: 6807845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
    Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
    Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture of Cryptococcus neoformans in the nonencapsulated state.
    Tripp C; Ruiz A; Bulmer GS
    Mycopathologia; 1981 Dec; 76(3):129-31. PubMed ID: 7033796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.